Eli Lilly (LLY) FCF Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (3y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-7.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-537.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-911.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,568.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
534.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
913.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
9,115.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-1,716.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 31, 2026 |
-7.00 |
| Dec 31, 2025 |
-1,240.00 |
| Sep 30, 2025 |
1,530.00 |
| Jun 30, 2025 |
-359.00 |
| Mar 31, 2025 |
-2,640.00 |
| Dec 31, 2024 |
-1,740.00 |
| Sep 30, 2024 |
153.00 |
| Jun 30, 2024 |
-1,855.00 |
| Mar 31, 2024 |
-1,848.00 |
| Dec 31, 2023 |
-3,307.00 |
| Sep 30, 2023 |
-1,179.00 |
| Jun 30, 2023 |
-4,153.00 |
| Mar 31, 2023 |
1,314.00 |
| Dec 31, 2022 |
-1,086.00 |
| Sep 30, 2022 |
28.00 |
| Jun 30, 2022 |
-187.00 |
| Mar 31, 2022 |
2,551.00 |
| Dec 31, 2021 |
593.00 |
| Sep 30, 2021 |
-1,578.00 |
| Jun 30, 2021 |
-94.00 |
| Mar 31, 2021 |
1,650.00 |
| Dec 31, 2020 |
-282.00 |
| Sep 30, 2020 |
-433.00 |
| Jun 30, 2020 |
1,571.00 |
| Mar 31, 2020 |
-115.00 |
| Dec 31, 2019 |
-94.00 |
| Sep 30, 2019 |
-486.00 |
| Jun 30, 2019 |
-701.00 |
| Mar 31, 2019 |
979.00 |
| Dec 31, 2018 |
725.00 |
| Sep 30, 2018 |
1,814.00 |
| Jun 30, 2018 |
706.00 |
| Mar 31, 2018 |
992.00 |
| Dec 31, 2017 |
95.00 |
| Sep 30, 2017 |
36.00 |
| Jun 30, 2017 |
836.00 |
| Mar 31, 2017 |
177.00 |
| Dec 31, 2016 |
598.00 |
| Sep 30, 2016 |
-248.00 |
| Jun 30, 2016 |
-391.00 |
| Mar 31, 2016 |
-1,163.00 |
| Dec 31, 2015 |
-850.00 |
| Sep 30, 2015 |
-827.00 |
| Jun 30, 2015 |
-556.00 |
| Mar 31, 2015 |
-1,877.00 |
| Dec 31, 2014 |
-778.00 |
| Sep 30, 2014 |
-227.00 |
| Jun 30, 2014 |
-1,422.00 |
| Mar 31, 2014 |
-1,690.00 |
| Dec 31, 2013 |
-1,022.00 |
| Sep 30, 2013 |
103.00 |
| Jun 30, 2013 |
-613.00 |
| Mar 31, 2013 |
-1,123.00 |
| Dec 31, 2012 |
-973.00 |
| Sep 30, 2012 |
402.00 |
| Jun 30, 2012 |
601.00 |
| Mar 31, 2012 |
1,425.00 |